Genicular Artery Embolization (GAE) represents a new paradigm in treating knee osteoarthritis that had hitherto been handled by resorting to either temporary or surgical solutions. With an ideal blend ...

Individuals with type 2 diabetes and painful symptomatic knee osteoarthritis are less likely to achieve target glycemic ...

Organogenesis Holdings ($ORGO) announced an update on their ongoing clinical study. Study Overview Organogenesis Holdings (ORGO) is sponsoring a ...

Osteoarthritis (OA) remains one of the leading causes of disability worldwide, burdening health systems and diminishing quality of life ...

Looking to improve your joint health? Fitness experts recommend these eight exercises for stronger joints and better mobility ...

What’s the best type of exercise for lowering knee pain and improving daily function for those with knee osteoarthritis?

SereNeuro Therapeutics revealed promising results for SN101, a first-in-class iPSC-derived therapy designed to treat chronic ...

The PPV-06 vaccine was safe, immunogenic, and linked with functional improvement at 42 weeks in a phase 1 trial of inflammatory knee osteoarthritis.

In a new clinical trial, people with obesity and knee osteoarthritis who took an experimental drug from Eli Lilly lost large ...

Lifestyle adjustments like maintaining a healthy weight and engaging in regular, low impact exercise can significantly alleviate osteoarthritis symptoms, particularly in the knees and hips. Various ...

Investing.com -- Organogenesis Holdings Inc (NASDAQ:ORGO) stock rose 1.9% in after-hours trading Tuesday after the regenerative medicine company announced it has begun a rolling submission of a ...

A generic product for managing pain and inflammation associated with osteoarthritis (OA) in canines has been approved by FDA ...